Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-04

Clinical Trial Update: Effectiveness of Arginine as a Treatment for Sickle Cell Anemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating L-Arginine as a treatment for sickle cell disease has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Anemia, Sickle Cell | Phase 2 | Status: COMPLETED | Results posted: 2009-08-04